Information Technology·Application Software·$8.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.71 | N/A | +22.41% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.71 | N/A | +22.41% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their focus on improving operational efficiencies.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to enhance operational efficiencies.
The earnings report shows that Manhattan Associates Inc exceeded expectations on EPS, which contributed to a slight increase in stock price. However, the lack of revenue figures and guidance may leave investors uncertain about future performance. The stock's modest reaction suggests that while the EPS beat is positive, investors are looking for more comprehensive insights into the company's overall health.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BIOGEN INC
Jan 28, 2013